Latest Corporate News News
FDA Approves Eli Lilly's Once-Daily Weight Loss Pill
Eli Lilly received FDA approval for its once-daily weight-loss pill on Wednesday, setting up direct competition with Novo Nordisk's Wegovy pill that launched at the start of the year. The approval intensifies the battle for dominance in the booming $70 billion-plus GLP-1 market for weight-loss and diabetes drugs, with analyst David Risinger describing it as a potential "battle royal" between the two pharmaceutical giants
.
Oil Prices Surge Following Trump's Iran Conflict Address
Oil prices rose more than 6-7% after President Trump signaled the U.S. would continue striking Iran "extremely hard" in his Wednesday night address. Brent crude climbed to nearly $108 per barrel as markets expressed concern that the conflict could conclude without reopening the Strait of Hormuz, a critical shipping route for roughly a fifth of global oil and gas
.
Asian Equities Decline Amid Market Volatility
Major Asian stock indices fell sharply following Trump's Iran remarks, with Japan's Nikkei 225 dropping 2.6%, South Korea's Kospi falling 5.2%, and China's Shanghai Composite slipping 1.1%. Hong Kong's Hang Seng declined 1.4% while Australia's S&P/ASX 200 and Taiwan's Taiex also posted losses amid geopolitical uncertainty
.
Precious Metals Face Downward Pressure
Gold and silver prices declined as markets reacted to Trump's escalatory Iran rhetoric, with gold falling 2% to $4,718.70 per ounce and silver dropping 4.9% to $72.39. The shift in precious metals reflected broader market sentiment favoring oil equities over traditional safe-haven assets.
Trump Administration Faces Economic Concerns Over War Costs
Economists have issued increasingly dire predictions about the economic consequences of the Iran conflict, revising down growth estimates while raising projections for inflation and unemployment. Trump's recent speech largely brushed off these concerns as temporary, even as Americans continue experiencing high gas prices from the ongoing conflict
.
U.S. Markets Show Mixed Performance Before Asia Selloff
Wednesday's U.S. session ended on a positive note with the S&P 500 gaining 0.7% to 6,575.32, the Dow Jones rising 0.5% to 46,565.74, and the Nasdaq advancing 1.2% to 21,840.95. However, these gains proved short-lived as Asian markets reversed course following Trump's late Wednesday address on Iran policy
.
Novo Nordisk Faces New Competition in GLP-1 Market
Novo Nordisk's Wegovy pill, which launched at the start of 2026, has had one of the best drug launches in history but now faces direct competition from Eli Lilly's newly approved alternative. The GLP-1 sector continues to expand rapidly as both companies vie for market leadership in the weight-loss drug category
.
Trump Signals Potential Near-Term End to Iran Military Operations
In his Wednesday address, Trump stated the U.S. would "finish the job" soon, indicating that core strategic objectives were nearing completion and military operations could conclude within weeks. However, market concerns persist regarding whether any peace agreement would reopen critical energy shipping routes
.
Geopolitical Tensions Impact Global Financial Markets
The combination of Trump's Iran rhetoric and ongoing trade concerns has created volatility across global equity and commodity markets. The divergence between U.S. markets and Asian markets reflects differing exposure to energy price shocks and geopolitical risk
.
Reciprocal Tariffs and Trade Policy Under Trump Administration
The Trump administration has announced new reciprocal tariffs on more than 60 trading partners, signaling continued emphasis on reducing America's trade reliance on China and other nations. The policy framework continues to influence global trade patterns and corporate planning strategies worldwide
.